(±)-Terbutaline and (±)-fenoterol are both arylethanolamine analogs that have tert-butyl and aryliso-propyl substituents respectively at the α position on the nitrogen of the ethanolamine side chain. In the present study, we have investigated the structure-activity relationships of (±)-terbutaline and (±)-fenoterol as β
3-adrenoceptor agonists in the guinea pig gastric fundus. (±)-Terbutaline and (±)-fenoterol induced concentration-dependent relaxation of the precontracted gastric fundus with pD
2 values of 4.45 ± 0.10 and 5.90 ± 0.09, and intrinsic activities of 1.00 ± 0.03 and 0.99 ± 0.01 respectively. The combination of the selective β
1-adrenoceptor antagonist (±)-atenolol (100 μM), and the selective β
2-adrenoceptor antagonist (±)-butoxamine (100 μM), produced a 2 and 6 fold rightward shift of the concentration-response curves for (±)-terbutaline and (±)-fenoterol respectively, without depressing the maximal responses. The order of potency of these agonists was (pD
2 value): (±)-fenoterol (5.09 ± 0.10) > (±)-terbutaline (4.13 ± 0.08). In the presence of (±)-atenolol and (±)-butoxamine, however, the non-selective β
1, β
2- and β
3-adrenoceptor antagonist (±)-bupranolol caused a concentration-dependent rightward shift of the concentration-response curves for (±)-terbutaline and (±)-fenoterol. Schild plot analyses of the effects of (±)-bupranolol against these agonists gave pA
2 values of 6.21 ± 0.07 ((±)-terbutaline) and 6.37 ± 0.06 ((±)-fenoterol) respectively, and the slopes of the Schild plot were not significantly different from unity (p>0.05). These results suggest that the relaxant responses to (±)-terbutaline and (±)-fenoterol are mainly mediated through β
3-adrenoceptors in the guinea pig gastric fundus. The β
3-adrenoceptor agonist potencies of arylethanolamine analogs depend on the size of the end of the alkylamine side chain.
View full abstract